Lytix Biopharma AS (LYTIX.OL) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · Norway · ISIN NO0010405780
Lytix Biopharma AS financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 11.13 m NOK | 0.00 NOK |
| Operating income | -95.90 m NOK | -64.03 m NOK |
| EBIT | -94.14 m NOK | -59.77 m NOK |
| Net income | -94.27 m NOK | -59.98 m NOK |
| Diluted EPS – continuing operations | -1.38 NOK | -0.88 NOK |
Full history since 2017, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Lytix Biopharma AS
Lytix Biopharma ASA, a clinical stage biotech company, develops novel cancer immunotherapies for cancer therapy in the United States. Its lead product candidate is ruxotemitide, an oncolytic molecule that is developed for intratumoral injections, which is in Phase III clinical trials, to treat melanoma, basal cell carcinoma, and advanced soft tissue sarcoma; and NeoLIPA Phase II study in combination with pembrolizumab. The company also offers LTX-401, an oncolytic molecule in preclinical phase for the treatment of deep-seated tumors, such as hepatocellular carcinoma in liver cancer and liver metastases. It has a partnership with Verrica Pharmaceuticals Inc. for the development and commercialization of ruxotemitide for the treatment of all malignant and pre-malignant dermatological indications. Lytix Biopharma ASA was founded in 2003 and is based in Oslo, Norway.
More stocks
- Cherry Hill Mortgage Investment Corp (CHMI)
- FLEXIBLE SOLUTIONS INTERNATIONAL INC (FSI)
- Covalon Technologies Ltd. (COV.V)
- JI-Tech Co., Ltd. (417500.KQ)
- Reitmans Canada Ltd (RET.V)
- Maronan Metals Ltd (MMA.AX)
- AIR T INC (AIRT)
- Milestone Pharmaceuticals Inc. (MIST)
- Rich Honour International Designs Co Ltd (6754.TW)
- Paramount Gold Nevada Corp. (PZG)
- Panamera Holdings Corp (PHCI)
- JUNIATA VALLEY FINANCIAL CORP (JUVF)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.